| November 29, 2016 | Israeli spinal implant company ApiFix has raised a $5 million Series B investment round, which will be closed by the end of next month. ApiFix is developing a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis (AIS). Based in Misgav in northern Israel, ApiFix is part of the Trendlines Group. B. Braun Melsungen Aesculap division has invested $2.8 million in the latest financing round.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments